Division Vote (Commons)
9 Jul 2025 - Universal Credit and Personal Independence Payment Bill -
View Vote Context
Danny Beales (Lab) voted Aye
- in line with the party majority
and in line with the House
One of
330 Labour Aye votes vs
37 Labour No votes
Vote Tally: Ayes - 335 Noes - 135
Division Vote (Commons)
9 Jul 2025 - Universal Credit and Personal Independence Payment Bill -
View Vote Context
Danny Beales (Lab) voted No
- in line with the party majority
and in line with the House
One of
364 Labour No votes vs
7 Labour Aye votes
Vote Tally: Ayes - 105 Noes - 370
Division Vote (Commons)
9 Jul 2025 - Universal Credit and Personal Independence Payment Bill -
View Vote Context
Danny Beales (Lab) voted No
- in line with the party majority
and in line with the House
One of
377 Labour No votes vs
0 Labour Aye votes
Vote Tally: Ayes - 103 Noes - 416
Division Vote (Commons)
9 Jul 2025 - Universal Credit and Personal Independence Payment Bill -
View Vote Context
Danny Beales (Lab) voted No
- in line with the party majority
and in line with the House
One of
377 Labour No votes vs
0 Labour Aye votes
Vote Tally: Ayes - 175 Noes - 401
Written Question
Wednesday 9th July 2025
Asked by:
Danny Beales (Labour - Uxbridge and South Ruislip)
Question
to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the randomised control trial study report entitled Cost utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data, published in June 2022, what assessment he has made of the potential implications for his policies of the findings of that study on the cost utility of adding abiraterone acetate plus prednisone/prednisolone to long term hormone therapy in men with newly diagnosed high risk non metastatic prostate cancer.
Answered by Karin Smyth
- Minister of State (Department of Health and Social Care)
NHS England considered abiraterone as an off-label treatment for hormone sensitive, non-metastatic prostate cancer through its clinical policy development process in 2024/25. Through this process, NHS England confirmed that there was sufficient supporting evidence to support the routine commissioning of abiraterone in this indication, and it was ranked in the highest priority level. However, at this point in time, it has not been possible to identify the necessary recurrent headroom in revenue budgets to support the funding of any treatments under consideration. This position is being kept under review.
NHS England examined papers from the STAMPEDE trial, including Cost utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data, as part of the review of evidence for the policy proposition.
Division Vote (Commons)
8 Jul 2025 - Football Governance Bill [Lords] -
View Vote Context
Danny Beales (Lab) voted No
- in line with the party majority
and in line with the House
One of
338 Labour No votes vs
0 Labour Aye votes
Vote Tally: Ayes - 167 Noes - 346
Division Vote (Commons)
8 Jul 2025 - Football Governance Bill [Lords] -
View Vote Context
Danny Beales (Lab) voted Aye
- in line with the party majority
and in line with the House
One of
331 Labour Aye votes vs
1 Labour No votes
Vote Tally: Ayes - 415 Noes - 98
Division Vote (Commons)
8 Jul 2025 - Football Governance Bill [Lords] -
View Vote Context
Danny Beales (Lab) voted No
- in line with the party majority
and in line with the House
One of
333 Labour No votes vs
0 Labour Aye votes
Vote Tally: Ayes - 178 Noes - 338
Division Vote (Commons)
8 Jul 2025 - Football Governance Bill [Lords] -
View Vote Context
Danny Beales (Lab) voted No
- in line with the party majority
and in line with the House
One of
336 Labour No votes vs
0 Labour Aye votes
Vote Tally: Ayes - 86 Noes - 340
Scheduled Event -
Friday 4th July
-
Add to calendar
View Source
Commons -
Adjournment - Main Chamber
Future of services for adults with learning difficulties in Hillingdon
MP:
Danny Beales